ZEB1 and non-small cell lung carcinoma: EMT has been shown as an important contributor to this resistance as TKI resistance NSCLC cell lines has a more mesenchymal phenotype, higher expression of mesenchymal markers, such as Zeb-1 and vimentin, and downregulation of E-cadherin [65].